Las Vegas, NV -- (SBWIRE) -- 10/23/2013 -- Titan Pharmaceuticals, Inc. (OTC:TTNP) trades at $0.92 after 9.528% fall in share price. With 82.54 million share volume, the market capitalization is touching 89.07 million. Last 52 weeks highest price was recorded $2.53 and lowest was $0.32.
Titan Pharmaceuticals announced that it successfully schedule meeting with officials in FDA to discuss the new drug. Food and Drug Administration agreed to meet company officials on November 19, 2013 for discussing Probuphine.
The company declared that FDA scheduled meeting as a Type C. The company thus submitted agenda and material on October 7, 2013.
Titan Pharmaceuticals is a pharmaceutical company that is manufacturing drugs related to the cure of various types of cancer, immunity diseases, viral diseases and the central nervous system disorders. Company mainly operates its processes in America.
To find out what OTCMAGIC projects for Titan Pharmaceuticals, Inc. for both short term and long term please click here: TTNP
OTCMAGIC Spends all day scouring the markets for the next huge Penny Stock Winner. Investors have come to trust us for our up to date commentary on all hot stocks so please visit OTCMAGIC right now and see what it’s all about for yourself! At 30,000 Visitors a Month and growing rapidly OTCMAGIC is the hottest thing in penny stocks!
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PLEASE NOTE: OTCMagic.com employees are not registered as an Investment Advisor in any jurisdiction whatsoever. Full disclaimer can be read at http://OTCMagic.com/disclaimer. Release of Liability: Through use of this website viewing or using you agree to hold OTCMagic.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss monetary or otherwise, damage monetary or otherwise, or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. OTCMagic.com affiliates may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. OTCMagic.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and OTCMagic.com. We make no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. This is not a solicitation to buy or sell any securities. Any claims or Statements should be deemed hypothetical. OTCMagic.com, nor any of its affiliates are not registered investment advisors or broker dealers.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)